This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

China is advancing its "health silk road" in Africa by initiating major offshore projects to manufacture essential medicines, such as insulin and antiretrovirals. Nigeria is set to produce ...

When Sunny Vohra acquired Twickenham Film Studios in 2012, he inherited more than just soundstages and post-production facilities. He became the custodian of a 113-year-old institution where cinema ...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...

LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other ...

To increase energy efficiency and reduce the carbon footprint of hydrogen fuel production, Fanglin Che, associate professor in the Department of Chemical Engineering at Worcester Polytechnic Institute ...

Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body's immune system destroy insulin-producing cells in the pancreas, which are ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...

Puratos is opening the first dedicated bakery glaze plant in the nation in late October in South Jersey. The new Ultra High Temperature facility in Camden County represents a significant development ...

From delaying the onset of type 1 diabetes with immunotherapy to restoring insulin production with stem cells and easing life through smart delivery systems, a new era of type 1 diabetes treatment is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Baricitinib preserved C-peptide levels and lowered ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...